Page 77 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰Ｘ機遇與未來大會手冊

陳緯 助研究員 Wei Chen, PhD

◼ Position/Affiliation/E-mail
Position/Affiliation:

Assistant Research Fellow (Assistant Professor) and Principal Investigator,
Genomics Research Center, Academia Sinica
E-mail: wchen123@as.edu.tw

◼ Biography
Professor Wei Chen received his B.S. and M.S. degrees in Chemistry from National Taiwan
University. He then received his Ph.D. degree in Chemistry from the University of California
Los Angeles (UCLA). Following this, he joined the Center for Nanomedicine, Brigham and
Women’s Hospital, Harvard Medical School, Harvard University as a postdoctoral researcher.
He is currently an assistant research fellow at the Genomics Research Center, Academia Sinica.
The Wei Chen Lab integrates expertise in nanomedicine, drug delivery technologies,
biomedical engineering, and biology. Our research focuses on developing advanced materials,
including engineered nanoparticles, siRNA/mRNA nanotechnologies, and “engineered living
materials” such as cells and bacteria. These platforms enable nano/microscale therapeutic
strategies for cancer, atherosclerotic cardiovascular disease, and inflammatory disorders.
Professor Chen has received numerous domestic and global awards, including 2030 Cross-
Generation Young Scholars Program, Emerging Young Scholars, National Science and
Technology Council (Taiwan); Nanoscale Emerging Investigator Award, Royal Society of
Chemistry (UK); Young Scientist Award, International Association of Advanced Materials
(Sweden); Japan Society for the Promotion of Science HOPE Fellow (Japan); American Heart
Association (AHA) Transformational Project Award, Co-Investigator, AHA, (US); and “Dr.
Yun MOU” Outstanding Young Scholar Award, Taiwan Nanomedicine Society (Taiwan), etc.
Professor Chen has so far authored more than 60 peer-reviewed papers including 25+ first-
author or corresponding-author papers in prestigious journals such as Nature Nanotechnology
2024, 19, 1386–1398; Nature Reviews Cardiology 2022, 19, 228–249 (Front Cover); Nature
Reviews Cardiology 2025, 22, 255–272; Circulation 2025 (minor revision); Nature
Communications, 2023, 14, 6973; Science Advances 2025, 11, adw7191; Science Advances
2021, 7, abi9265 (Front Cover); J. Am. Chem. Soc. 2023, 145, 8375-8388 (Cover Featured);
J. Am. Chem. Soc. 2019, 141, 12475–12480; J. Am. Chem. Soc. 2019, 141, 17670-17684;
Angew. Chem. Int. Ed. 2023, 62, e202308413 (Front Cover), Angew. Chem. Int. Ed. 2021,
60, 7155–7164 (Front Cover); Chem. Rev. 2025, in press (Cover); Chem. Rev. 2024 124, 929–
1033; Acc. Chem. Res. 2019, 52, 1531-1542; ACS Nano 2019, 13, 1292–1308; ACS Nano
2013, 7, 8423–8440; Matter (Cell Press) 2024; 7, 3811–3844; Matter (Cell Press) 2022, 5,
2471–247; Matter (Cell Press) 2022, 5, 18–19; Advanced Science 2023, 10, 2207439;
Advanced Science 2023, 10, 2207768, etc. The full list of our publications is available on
Google Scholar: https://scholar.google.com/citations?user=O8jZ2mUAAAAJ&hl=en

55